Io vitro susceptibility of Mycobacterium tuberculosis to fusidic acid
Articles > Article · 2001
Authors: Candan ÇİÇEK, Cengiz ÇAVUŞOĞLU, D Burhanoglu, S Hilmioglu, N OZKALAY, A BILGIC
CLINICAL MICROBIOLOGY AND INFECTION, Journal Indexed in SCI Expanded, International, 2001, vol 7, pp 700-702
DOI: 10.1046/j.1469-0691.2001.00341.x
Summary
The aim of this study was to determine the in vitro susceptibility of 170 clinical isolates of Mycobacterium tuberculosis to fusidic acid using a proportion dilution method. Nineteen isolates were resistant to at least one first line anti-tuberculosis drug. A total of 1.8% of the isolates were resistant to fusidic acid. Fusidic acid should be evaluated clinically as a potential supplementary drug for the treatment of infections due to multidrug-resistant strains of M. tuberculosis.